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Abstract. The goal of the present study was to separate a set of benzodiazepines, namely bromazepam, 
oxazepam, nitrazepam, chlordiazepoxide, flunitrazepam, lormetazepam and diazepam by analytical scale 
HPLC and CZE. The both methods for separation of these seven compounds from the 1,4-benzodiazepine 
group were optimized and compared. LODs and LOQs were determined under the optimized conditions in 
the both methods. The corresponding LOD and LOQ values are approximately three orders of magnitude 
lower in HPLC than in CZE. As expected, elution order was found to be different for the both techniques. 
As a result of a critical collation of all the parameters considered, RP-HPLC was found to be more suit-
able for determination of the set of benzodiazepines. A real sample analysis was performed under opti-
mized conditions to demonstrate applicability of the proposed analytical methods. (doi: 10.5562/cca1738) 
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INTRODUCTION 
1,4-benzodiazepines (BZDs) are a well-known class of 
psychoactive drugs; they are known primarily for their 
hypnotic and sedative effects.1 This pharmaceutical 
group is also used as anxiolytics, anticonvulsants and 
muscle relaxants.2 They are still widely prescribed but 
also abused.3,4 Many studies on these drugs can be found 
in the literature.5–8 Diverse analytical methods for deter-
mination of benzodiazepines in various matrices have 
been published,9,10 e.g. potentiometry,11 immunoassays,12 
spectrophotometry13 and also separation techniques that 
represent a clear majority of the reported methods be-
cause they allow determination of individual compounds 
in often rather complicated mixtures. While HPLC re-
mains the most common technique for the analysis of 
benzodiazepines,7,9,14,15 mainly in reversed phase (RP) 
mode, several capillary zone electrophoresis (CZE) me-
thods have recently been developed.2,16,17 CZE represents 
an interesting alternative to HPLC for determination of 
pharmaceuticals, in general,18,19 mainly because of its 
higher efficiency in comparison with HPLC.20 
The aim of this work was to develop and optimize 
separation conditions for a set of seven 1,4-BZDs in RP-
HPLC and CZE with UV detection and compare these 
methods in terms of efficiency, analysis time, resolu-
tion, elution order and basic validation parameters. The 
results aimed to answer the question if CZE is really a 
suitable alternative to RP-HPLC for the resolu-




Acetonitrile (ACN) for HPLC and methanol (MeOH) 
for HPLC were obtained from Sigma-Aldrich (Stein-
heim, Germany). Glacial acetic acid (HAc, purity > 99.5 
%), sodium dihydrogen phosphate anhydrous (purity ≥ 
99 %) and mesityl oxide were purchased from Fluka 
(Buchs, Switzerland). Sodium hydroxide solution (0.1 
mol/l) was from Agilent Technologies (Waldbronn, 
Germany). Ortho-phosphoric acid (85 %) was obtained 
from Lachema (Brno, Czech Republic). 1,4-
benzodiazepines, namely oxazepam, nitrazepam, lorme-
tazepam, chlordiazepoxide, flunitrazepam, diazepam 
and bromazepam, were obtained from Sigma-Aldrich 
(Steinheim, Germany). The tablets of Diazepam Slova-
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kofarma® 5 mg were product of Zentiva (Hlohovec, 
Slovakia) and Lexaurin® 3 (bromazepamum 3 mg) was 
product of KRKA (Novo mesto, Slovenia). Water was 
prepared with a Milli-Q water purification system (Mil-
lipore, Milford, MA, USA). Stock solutions of the ana-
lyzed compounds were prepared in concentration of 1 
mg/ml using MeOH as a solvent. 
 
Equipment and Measurement Conditions 
All chromatographic measurements were performed on 
a Waters Breeze HPLC system (Waters Chromatogra-
phy, Milford, MA, USA) consisting of a 1525 binary 
pump, a 717 plus autosampler, a column heater and a 
2487 dual λ absorbance detector. A Breeze software was 
used for process control and data handling. Columns 
used for separations were a Zorbax SB-C8 (column size 
150 mm × 4.6 mm i.d., particle size 5 μm) and Zorbax 
SB-C18 (column size 150 mm × 4.6 mm i.d., particle 
size 5 μm), both purchased from Agilent Technologies 
(USA). The columns were thermostated at 25 °C. Flow 
rate was 2 ml/min. Detection was carried out at the 
wavelength of 240 nm. Mobile phases were composed 
of ACN/deionised water with acetic acid, pH 3.0, in 
various ratios. Injected sample volume was 10 μL. Indi-
vidual measurements were repeated three times. 
Electrophoretic experiments were performed using 
an Agilent 3DCE equipment operated under control of a 
ChemStation software (Agilent Technologies, Waldbronn, 
Germany). Detection was performed with a diode array 
detector at the detection wavelength of 240 nm. A bare 
fused-silica capillary of 50 μm i.d. and 363 μm o.d. was 
product of Polymicro Technologies (Phoenix, USA). Total 
length of the capillary was 63.7 cm and length to the de-
tector was 55.2 cm. The capillary was thermostated at 25 
°C. Driving voltage was +27 kV (with cathode at the 
detector side). Samples were injected hydrodynamically: 
50 mbar × 5 s. Mesityl oxide was used as an electroosmo-
tic flow (EOF) marker. Stock solutions of sodium dihydro-
gen phosphate and ortho-phosphoric acid at a concentra-
tion of 50 mM were used for preparation of background 
electrolyte (BGE). The running buffer was prepared by 
mixing of appropriate amounts of the stock solutions and 
addition of water to obtain BGE with final composition of 
6 mM sodium dihydrogen phosphate and 33 mM ortho-
phosphoric acid. pH value of the BGE was 2.0. The capil-
lary was rinsed with pure water for 10 min, with 0.1 mM 
NaOH for 10 min, 10 min with pure water again and 20 
min with running buffer before use. Prior to each measure-
ment the capillary was washed with the running buffer for 
4.5 min. All measurements were carried out in triplicates. 
 
Procedures 
Real Sample Preparation 
Aliquots of powdered tablet samples were dissolved in 
methanol to concentration of 1 mg/ml. The samples 
were sonicated for 20 min to provide complete dissolu-
tion. Appropriate volumes of clear supernatants were 
diluted with methanol to concentration of 0.01 mg/ml 
and with BGE to concentration of 0.05 mg/ml for HPLC 
and CZE analyses, respectively. The prepared samples 
were filtered through a 0.45 μm filter before injection. 
The total amounts of the drugs were then determined 
using the optimized HPLC and CZE methods. 
 
Statistical Data Evaluation 
One-way analysis of variance (ANOVA) statistical 
method was used for robustness testing. Parameters, 
which could become significant sources of errors in 
practice, were chosen as variables. The significance 
level (α) was set at 0.05. The one-way analysis of va-
riance compares the medians of two or more groups in 
order to determine if at least a median value of one 
group is different from the others. The tests are nondi-
rectional as the null hypothesis specifies that all me-
dians are equal and the alternative hypothesis simply 
states that at least one median value is different.21 If the 
statistical p-value is higher than the chosen significance 
level, the null hypothesis of the equal medians is ac-
cepted. 
 
RESULTS AND DISCUSSION 
Optimization of the Chromatographic 
Separation Conditions 
Optimization of separation conditions for seven drugs 
from 1,4-benzodiazepine group – bromazepam, oxaze-
pam, nitrazepam, chlordiazepoxide, flunitrazepam, 
lormetazepam and diazepam - was carried out in RP-
HPLC system.2,7,14,15 The first column tested was Zor-
bax SB-C8 packed with an endcapped octyl-silica gel 
stationary phase. The most suitable mobile phase com-
position found in isocratic elution mode was 
ACN/deionised water with acetic acid, pH 3.0, 30/70 
(v/v). Baseline resolution of all seven analytes was 
achieved within 20 minutes – see Figure 1A. Compared 
to mobile phase composed just of ACN and deionised 
water the acidified mobile phase enhanced peak symme-
try. Various linear gradient elution types were tested to 
decrease the analysis time. To preserve baseline resolu-
tion of a critical pair of flunitrazepam and lormetazepam 
the acetonitrile gradient could not be applied before 11th 
minute. As the result of application of the gradient 
shorter analysis time was reached while the peak sym-
metry was preserved. However, the isocratic mode is 
more suitable for routine (repeated) measurements be-
cause it does not require column equilibration before 
each analysis. 
Using column with more hydrophobic stationary 
phase octadecyl-silica gel SP – Zorbax SB-C18 – the 
analysis time was substantially reduced because a mo-
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bile phase with higher ACN content (40 volume per-
cent) could be applied while the separation was still 
preserved. The baseline resolution of all seven 1,4-
BZDs was achieved within 7 min (Figure 1B). Linear 
gradient elution was also tested. Using the Zorbax SB-
C18 column and mobile phase composed of ACN/water 
with HAc, pH 3.0, 40/60 (v/v) and a linear gradient to 
volume fraction φ = 90 % of acetonitrile applied from 
2nd to 3rd minute, the analysis time was reduced to 4.5 
minute. The results obtained under isocratic versus 
gradient elution conditions are summarized in Table 1 
for comparison. The peak symmetry was similar under 
the both studied conditions. Therefore, the isocratic 
elution was selected as the optimized separation mode. 
The efficiency, expressed as plate number/meter of 
column, ranged under optimized isocratic conditions 
from 2.05 × 104 to 6.00 × 104 while under gradient elu-
tion conditions this parameter rendered higher values, 
from 1.97 × 104 to 3.55 × 105. 
 
Optimization of the Electrophoretic  
Separation Conditions 
The software PeakMaster22 was utilized for selection of 
an initial BGE composition, pH and separation condi-
tions. The optimized BGE composition for the analysis of 
BZDs was 6 mM sodium and 39 mM phosphate ions. 
According to PeakMaster calculations the optimized BGE 
had pH 2.0, ionic strength 17.2 mM and buffering capaci-
ty 48 mM. Nitrazepam was excluded from the studied set 
of analytes because of its instability in the buffer of the 
low pH. Using 6 mM phosphate buffer of higher pH the 
compounds were not baseline resolved. Baseline separa-
tion of six BZDs was obtained within 36 minutes with the 
BGE of pH 2.0. To reduce the analysis time additional 
pressure of 50 mbar was applied in 10th min. Then the 
analysis time decreased to 17 minutes with baseline sepa-
ration preserved – see Figure 2. The additional pressure 
could not be used earlier (before the 10th min) because it 
would not allow baseline resolution of the first three com-
pounds (bromazepam, diazepam and chlordiazepoxide). 
The efficiency, expressed as plate number / meter, ranged 
under optimized conditions from 1.11 × 105 to 3.08 × 105. 
The plate number of the lormetazepam peak was calcula-
ted to be an order of magnitude lower in comparison with 
all the other peaks obtained in the CZE measurements. 
This is caused by a resonance phenomenon23,24 that can 
lead to anomalous dispersion of the analyte´s peak.25 The 
resonance can cause false results of analysis. It was de-
scribed to have also a negative impact on efficiency of 
separation.26 Therefore, it is better to avoid using separa-
tion conditions at which the resonance occurs. 
Figure 1. Chromatograms of 1,4-benzodiazepines separation.
Chromatogram A: Zorbax SB-C8 column; mobile phase:
ACN/water with HAc, pH 3.0, 30/70 (v/v); 2 ml/min; 25 °C;
240 nm. Chromatogram B: Zorbax SB-C18 column; mobile
phase: ACN/water with HAc, pH 3.0, 40/60 (v/v); 2 ml/min;
25 °C; 240 nm. Elution order: 1-chlordiazepoxide, 2-
bromazepam, 3-oxazepam, 4-nitrazepam, 5-flunitrazepam, 6-
lormetazepam, 7-diazepam. 
Table 1. Comparison of retention time (tR), resolution (R) and peak symmetry (S) for isocratic and gradient elution with Zorbax 
SB C18 column. Mobile phase compositions: isocratic elution: ACN/deionised water with HAc, pH 3.0, 40/60 (v/v); gradient 
elution: ACN/deionised water with HAc, pH 3.0, 40/60 (v/v) in isocratic elution up to 2nd minute and a linear gradient to volume 
fraction, φ = 90 % of ACN applied from 2nd to 3rd mins 
 tR /min R  S 
peak number         compound iso grad iso grad  iso grad 
1         chlordiazepoxide 1.32 1.31    1.21 1.16 
2         bromazepam 1.76 1.76 4.44 4.33  1.12 1.14 
3         oxazepam 2.41 2.41 5.61 5.60  1.05 1.07 
4         nitrazepam 2.74 2.73 2.50 2.53  1.05 1.06 
5         flunitrazepam 4.09 3.90 8.39 10.03  1.03 0.99 
6         lormetazepam 4.60 4.06 2.65 1.75  1.01 1.04 
7         diazepam 6.83 4.40 9.07 4.36  1.02 1.01 
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Validation of the Methods 
Stability of Sample Solutions 
Stability of the sample solutions (1 mg/ml MeOH) kept at 
low temperature was tested by the optimized HPLC me-
thod during the period of three weeks. Almost all the 
samples were proved to be stabile over the three weeks 
period. The only exception was solution of chlordiazepox-
ide that showed slight instability after five days of storage. 
However, it was still useful for the purpose of this study. 
 
Precision 
In order to evaluate the precision of the HPLC and CZE 
methods, repeatability and reproducibility of measure-
ments were studied at the wavelength of 240 nm. The 
repeatability of the retention factors and sample con-
centrations in HPLC and the effective mobilities and 
sample concentrations in CZE were determined as 
relative standard deviations (R.S.D.) for 10 consecutive 
injections of the set of 1,4-benzodiazepines at the con-
centrations of 0.01 mg/ml and 0.05 mg/ml in HPLC and 
CZE, respectively. The reproducibility of the chroma-
tographic and electrophoretic data (retention factor, 
effective mobility, sample concentration) of the tested 
set of analytes was measured in the period of 3 days by 
different scientists. The R.S.D. values for precision of 
the both methods are shown in Table 2. The results 
suggest that the HPLC and CZE methods are suitable 




The linearity was tested over the concentration range 
0.001 to 0.1 mg/ml and 0.02 to 0.1 mg/ml in HPLC and 
CZE, respectively. Measurements at all concentration 
levels were carried out in triplicate at six concentration 
levels and all values of peak areas were subjected to 
linear regression. Linear relationships between the peak 
areas in HPLC or the corrected peak areas (peak 
area/migration time) in CZE and the concentrations of 
individual 1,4-benzodiazepines were observed – see 
Table 3. 
Figure 2. Electropherogram of 1,4-benzodiazepines separa-
tion. BGE: 6 mM phosphate buffer, pH 2.0; +27 kV; 25 °C;
240 nm. Elution order: 1-bromazepam, 2-diazepam, 3-
chlordiazepoxide, 4-flunitrazepam, 5-oxazepam, 6-lormeta-
zepam in coincidence with stationary system peak, x-impu-
rities. Baseline "jump" at 10th min is caused by application
of pressure. 
Table 2. Precision, expressed as relative standard deviation values of concentrations, retention factors and effective mobilities, of 
the developed HPLC and CZE methods for analysis of 1,4-BZDs 
 
HPLC CZE 
























  chlordiazepoxide 0.965 0.229 1.66 0.635 3.94 0.950 14.7 2.06 
  bromazepam 0.999 0.188 1.81 0.262 4.11 0.743 9.09 1.11 
  oxazepam 0.985 0.108 1.37 0.245 4.74 0.732 8.12 0.326 
  nitrazepam 0.943 0.145 1.18 0.313 x x x x 
  flunitrazepam 1.24 0.131 1.30 0.261 4.11 0.486 8.87 0.439 
  lormetazepam 1.14 0.123 1.70 0.227 x x x x 
  diazepam 1.07 0.132 2.20 0.362 4.10 0.903 11.2 1.19 
c, concentration; k, retention factor; eff, effective mobility; R.S.D, relative standard deviation. 
repeatability – the R.S.D. values were calculated from ten consecutive injections of the mixture of analytes. 
reproducibility – the R.S.D. values were calculated from measurements obtained by different scientists within a period of 3 days. 
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Limit of Detection and Limit of Quantification 
The limit of detection (LOD), expressed as a concen-
tration at a signal-to-noise ratio 3:1, was calculated on 
the basis of the baseline noise, which was evaluated 
by recording the detector response over a period of 
approximately ten times the widths of the peaks. The 
signal-to-noise ratio of 10:1 was used to determine the 
limit of quantification (LOQ). LODs and LOQs were 
calculated for all seven 1,4-benzodiazepines under the 
optimized isocratic HPLC conditions. Under the  
optimized separation conditions in CZE LODs and 
LOQs were determined for the five separated BZDs.  
It was not possible to quantify the peak of lormetaze-
pam because its mobility (at the pH of the BGE) was 
very close to zero and therefore close to the mobility 
of the stationary system peak. The observed resonance 
substantially changed the peak height (area), which 
could not be used anymore for quantification of the 




One-way ANOVA statistical method was used for ro-
bustness testing. The selected variable parameters of the 
HPLC method were: column temperature (24 °C, 25 °C 
and 26°C), pH of the aqueous part of the mobile phase 
(2.8, 3.0 and 3.2) and acetonitrile content in the mobile 
phase (40 % ± 2 %). The tested parameters of the CZE 
method were: temperature (24 °C, 25 °C and 26 °C) and 
background electrolyte pH (2.0 ± 0.2 pH units). The 
robustness was determined from triplicate injections of 
0.01 mg/ml of the set of seven 1,4-BZDs and of 0.05 
mg/ml of the set of five 1,4-BZDs in HPLC and CZE, 
respectively, for every change of the tested parameters. 
The effect of the method parameters on retention factors 
or effective mobilities and analytes concentrations was 
calculated. The hypothesis that errors resulted from a 
normal distribution was tested first. This hypothesis was 
accepted in all cases (at α = 0.05). Consequently, the 
robustness of the method was examined using the one-
way ANOVA - see Experimental. The null hypothesis  
 
Table 3. Linearity – parameters of the obtained linear regression equations
 
















  chlordiazepoxide   2.85 −56 0.9992 41.5  2.85 5 0.9919 14.5 
  bromazepam   2.80 −7.2 0.9999 4.41  1.09 5 0.9949 3.79 
  oxazepam 23.32 −4.7 0.9999 3.37  1.19 1 0.9987 2.62 
  nitrazepam 15.93 4 0.9999 7.54  x x x x 
  flunitrazepam 13.49 −3.6 0.9999 3.04  0.41 0.4 0.9956 1.38 
  lormetazepam 21.77 −10 0.9999 12.0  x x x x 
  diazepam             26.9 5 0.9998 11.8  2.34 3 0.9982 5.40 
 
 
Table 4. LOD and LOQ data under optimized separation conditions – see the text 
 HPLC  CZE 
 LOD / ng ml−1 LOQ / ng ml−1  LOD / μg ml−1 LOQ / μg ml−1 
  chlordiazepoxide 8.68 28.9  1.63 5.44 
  bromazepam 7.89 26.3  4.27 14.3 
  oxazepam 8.91 29.7  2.98 9.94 
  nitrazepam 17.1 56.8  x x 
  flunitrazepam 26.7 89.0  11.2 37.3 
  lormetazepam 17.8 59.2  x x 
  diazepam 22.8 75.9  1.57 5.22 
x - not quantified. 
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was accepted in almost all cases (obtained p-values 
were higher than 0.05), so the robustness of the selected 
parameters of the methods was verified. An exception 
was the background electrolyte pH. The effect of an 
increase of the BGE pH value on the effective mobility 
and concentration of chlordiazepoxide and diazepam 
could not be evaluated by one-way ANOVA due to their 
co-migration. 
 
Real Sample Analysis – Accuracy 
Two different tablets containing 10 mg of diazepam and 
3 mg of bromazepam were analyzed three times in con-
centrations of 0.01 mg/ml and 0.05 mg/ml using the 
optimized HPLC and CZE methods, respectively. Accu-
racy of the methods, regarded as the closeness of 
agreement between the claimed contents of tablets and 
the found values, were 103.2 % for bromazepam and 
102.9 % for diazepam by the HPLC method. Accuracy 
of the CZE analyses were 109.8 % for bromazepam and 
103.2 % for diazepam. The reports of the analyses of 
diazepam are shown in Figure 3. The same results can 
be achieved for other pharmaceutical preparations con-
taining BZDs. 
 
Comparison of HPLC and CZE Methods 
RP-HPLC and CZE methods for separation of 1,4-
benzodiazepines were developed and optimized. The 
HPLC analysis under isocratic elution conditions can be 
achieved within 7 mins, application of mobile phase 
gradient can reduce the analysis time to 4.5 minutes. 
Separation of 1,4-benzodiazepines requires separation 
time of 17 minutes in the optimized CZE system if addi-
tional pressure is applied. The LOD and LOQ values are 
approximately three orders of magnitude lower in 
HPLC than in CZE. There are two reasons for these 
quantification results in CZE: (i) the baseline noise is 
much higher in CZE than in HPLC, and (ii) lower sam-
ple volume is injected in CZE (6 nl) in comparison with 
HPLC (10 μl). On the other hand the plate number / me-
ter is an order of magnitude higher in CZE than in HPLC. 
Narrower profiles of peaks obtained in capillary zone 
electrophoresis can make easier and more reliable quanti-
fication from the peak height (compare the analyte´s 
peaks in Figure 3). 
 
CONCLUSION 
HPLC and CZE were proved to be suitable methods for 
separation of benzodiazepines and for their qualitative 
and quantitative analyses in pharmaceutical formula-
tions. From the results obtained it is obvious that the 
method of first choice is RP-HPLC. 
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